In this article, we will discuss the 10 Most Profitable Growth Stocks to Buy.
On May 26, Michael Dehal, Senior Portfolio Manager at Dehal Investment Partners of Raymond James Ltd., appeared on BNN Bloomberg to discuss the outlook for the markets. The US economy currently exhibits resilience, significantly supported by robust investment led by AI. However, investors are confronting challenges such as re-accelerating inflation, rising energy prices linked to tensions in the Middle East, and the potential for interest rates to remain higher for a longer period. Dehal confirmed that the 2% growth seen in the US economy during Q1 was heavily driven by business investment, specifically AI infrastructure and investments.
He highlighted that the 26% year-over-year earnings growth observed in Q1 was largely tied to this AI build-out within tech companies, positioning AI as a current tailwind for the economy. While business spending and investment remain high, consumer spending is beginning to slow. Dehal explained that consumers are cautious and noted that recent consumer sentiment numbers in the US reached their lowest point in 3 to 4 decades. This caution stems from the ongoing war, higher prices, and increased oil and gasoline costs, which are particularly notable as the summer months approach and demand for travel and road activity typically rises. Consequently, while businesses remain somewhat upbeat, they are also exercising caution heading into the summer and the third quarter.
Dehal also observed that the S&P 500 has seen a significant rally since the March 30 lows. However, he expresses concern that the market is becoming increasingly narrow, as this rally is powered by only a handful of stocks, primarily within the tech and AI sectors. He emphasized that a broadening market is healthier, and the current narrowness is worrisome because those specific stocks could shift, potentially leading to negative market moves.
Our Methodology
We used screeners to identify stocks that have grown their revenue by at least 30% over the past 3 years, as well as reported high TTM net income (at least $500 million) and TTM net income margin (at least 15%). We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds. The stocks are ranked in ascending order of their net income.
Note: All data was sourced on June 5.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
10 Most Profitable Growth Stocks to Buy
10. Kinsale Capital Group Inc. (NYSE:KNSL)
TTM Net Income: $527 million
Kinsale Capital Group Inc. (NYSE:KNSL) is one of the most profitable growth stocks to buy. On April 29, Kinsale Capital Group announced that the company is realigning its Analytics and Technology departments under the unified leadership of Salmaan K. Allibhai, who has been promoted to Executive VP, Chief Analytics & Technology Officer. This organizational shift is designed to eliminate operational silos and better integrate data and technology strategies to drive the company’s quantitative approach to profitability and efficiency.
Concurrent with this change, Nicholas J. Kunkle has been promoted to VP, Chief Actuary to manage the Analytics and Actuarial department. These leadership updates follow the retirement of Diane Schnupp, the former Executive VP and CIO, who will remain in a consulting role to facilitate a smooth transition after 7 years of service.
CEO Michael P. Kehoe expressed gratitude for Schnupp’s contributions while noting that Allibhai’s extensive experience within the firm makes him well-suited to oversee the company’s end-to-end systems. By consolidating these critical functions, Kinsale aims to enhance its ability to harness data for faster, smarter decision-making in an evolving business environment.
Kinsale Capital Group Inc. is a US specialty insurance company focused on the excess and surplus lines market, underwriting complex or hard‑to‑place commercial property and casualty risks that standard insurers avoid. It operates nationwide through independent brokers, emphasizing disciplined underwriting, proprietary technology, and strong risk selection to drive consistent profitability and growth.
9. FTAI Aviation Ltd. (NASDAQ:FTAI)
TTM Net Income: $536 million
FTAI Aviation Ltd. (NASDAQ:FTAI) is one of the most profitable growth stocks to buy. On May 22, FTAI Aviation successfully priced its inaugural asset-backed securitization, FTAI MRE 2026-1, totaling $612 million. The offering is backed by aircraft currently on lease to 23 global airlines and consists of two classes of investment-grade notes.
The transaction, which serves as a milestone for the company’s Strategic Capital vehicle, saw significant oversubscription due to strong investor demand. This success underscores FTAI Aviation Ltd.’s (NASDAQ:FTAI) leadership in the narrowbody aircraft market and its ability to integrate engine maintenance expertise with aircraft ownership.
ATLAS SP Partners and Deutsche Bank acted as joint lead bookrunners, supported by a broad group of financial institutions. The company highlighted that this initiative effectively diversifies its financing sources while strengthening its position within the capital markets.
FTAI Aviation Ltd. is a leading provider of aviation leasing and maintenance services, specializing in CFM56 and V2500 engine aftermarket support.
8. Ascendis Pharma (NASDAQ:ASND)
TTM Net Income: $573 million
Ascendis Pharma (NASDAQ:ASND) is one of the most profitable growth stocks to buy. On May 7, Ascendis Pharma reported strong financial results for Q1 2026, reaching a total revenue of €247 million. This growth was primarily driven by YORVIPATH, which generated €197 million, alongside €44 million from SKYTROFA. Additionally, the company announced an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $187.5 million, further strengthening its financial position.
The company is experiencing robust commercial momentum, highlighted by over 1,000 new US patient enrollments for YORVIPATH and more than 60 enrollments for YUVIWEL following its early April launch. Ascendis is also advancing its clinical pipeline, including positive results from the COACH combination therapy trial, while making the strategic decision to discontinue internal oncology development to better align with its long-term focus.
Operational updates for the quarter include a transition to trading ordinary shares on the Nasdaq Global Select Market and the full redemption of its 2028 convertible notes. With a net profit of €629 million and cash reserves of €573 million as of March 31, Ascendis Pharma continues to solidify its role as a leading global biopharmaceutical firm.
Ascendis Pharma develops TransCon-based therapies for unmet medical needs.
7. Globus Medical Inc. (NYSE:GMED)
TTM Net Income: $586 million
Globus Medical Inc. (NYSE:GMED) is one of the most profitable growth stocks to buy. On May 7, Globus Medical reported a strong start to 2026, with worldwide net sales reaching $759.9 million for Q1, representing a 27.0% increase. The company’s core spine business and enabling technologies drove organic revenue growth of 13.2%, while GAAP net income rose to $124.3 million. Diluted EPS saw significant gains, with GAAP EPS reaching $0.90 and non-GAAP EPS hitting $1.12.
Leadership attributed this success to disciplined manufacturing, supply chain initiatives, and structural cost management, which fueled margin expansion. The US spine division maintained a steady growth trajectory, marking its third consecutive quarter of 10% year-over-year growth. Meanwhile, the integration of the recently acquired Nevro business continues to proceed as expected.
Following these results, Globus Medical Inc. has reaffirmed its full-year 2026 revenue guidance of $3.18 billion to $3.22 billion. Due to strong performance, the company updated its non-GAAP fully diluted EPS outlook, raising the projected range to $4.70-$4.80 from its previous guidance of $4.40-$4.50.
Globus Medical Inc. is a medical device company involved in the development and commercialization of healthcare solutions. The company classifies its products into Innovative Fusion and Disruptive Technology, and operates through the US and International geographical segments.
6. IAMGOLD Corporation (NYSE:IAG)
TTM Net Income: $1.00 billion
IAMGOLD Corporation (NYSE:IAG) is one of the most profitable growth stocks to buy. On June 1, IAMGOLD announced an updated consolidated Mineral Resource estimate for the Côté Gold Mine in Ontario, Canada, reporting 20.3 million ounces of Measured and Indicated gold, a 12% increase from the end of 2025. This update integrates the Côté and Gosselin zones into a single geological framework, bolstered by recent drilling that successfully expanded resources in the connecting “saddle” area.
The estimate utilizes updated economic assumptions, including a $2,500 per ounce gold price and a lower cut-off grade of 0.25 g/t Au, to better reflect current market conditions. Consequently, Inferred Mineral Resources also saw significant growth, rising 61% to 3.5 million ounces, further strengthening the project’s long-term geological profile.
This consolidated model serves as a key milestone for the joint venture, which is currently preparing for a plant expansion and larger-scale mining scenario. The updated data will be foundational to the upcoming Côté Gold Technical Report and comprehensive mine plan, both of which remain on track for release in Q4 2026.
IAMGOLD Corporation is a mining company engaged in the exploration, development, and production of gold. Its operations include producing assets such as the Essakane mine in Burkina Faso and the Westwood mine in Canada, alongside development projects like the Côté Gold project in Ontario.
5. Interactive Brokers Group Inc. (NASDAQ:IBKR)
TTM Net Income: $1.04 billion
Interactive Brokers Group Inc. (NASDAQ:IBKR) is one of the most profitable growth stocks to buy. On June 1, Interactive Brokers introduced agentic trading by integrating directly with Claude, allowing clients to research stocks, analyze portfolio performance, and generate trade instructions using the AI platform. This secure integration enables users to connect their existing accounts through a certified connector marketplace, providing access to over 170 global markets without the need for additional accounts or shared passwords.
The system uses a “human-in-the-middle” design, ensuring that while the AI can process natural language queries (such as portfolio concentration or rebalancing needs), it cannot execute trades independently. Instead, all trade instructions are sent to a dedicated tab across IBKR platforms, where clients must manually review and approve them before they are submitted as official orders into the marketplace.
This feature currently supports equities and ETFs, with plans to expand to further asset classes soon. Furthermore, integrations for ChatGPT, Gemini, and Grok are undergoing certification. This launch complements Interactive Brokers Group Inc.’s (NASDAQ:IBKR) existing suite of AI tools, which includes natural language screeners, thematic investment searches, and automated news summaries, all designed to enhance investor decision-making.
Interactive Brokers Group Inc. is a global automated electronic broker that provides execution, clearance, and custody services across diverse asset classes. The company offers advanced trading platforms and specialized account services to both institutional and individual investors.
4. Futu Holdings Limited (NASDAQ:FUTU)
TTM Net Income: $1.28 billion
Futu Holdings Limited (NASDAQ:FUTU) is one of the most profitable growth stocks to buy. On May 28, Futu Holdings reported strong operational growth for Q1 2026, with funded accounts rising 34.3% year-over-year to 3.6 million and total client assets increasing 47.2% to HK$1.22 trillion. Trading volume reached a record HK$4.15 trillion, supported by increased activity in Hong Kong equities, while the company continued to diversify its wealth management offerings and secured a full-scale virtual asset license for its platform, PantherTrade.
Financially, total revenues grew 24.7% to HK$5.86 billion, driven by robust performance in brokerage commissions and interest income. However, net income decreased 61.2% to HK$831 million, primarily due to the recognition of an administrative penalty of ~RMB 1.85 billion from the China Securities Regulatory Commission, which the company noted does not affect its long-term business fundamentals or financial stability.
Chairman and CEO Leaf Hua Li reaffirmed the company’s full-year guidance of 800,000 net new funded accounts, citing broad-based strength across international markets despite periodic market volatility. With a solid balance sheet and ongoing expansion into new asset classes and regions, Futu Holdings Limited remains focused on scaling its global ecosystem and deepening its integrated investment services for its high-quality client base.
Futu Holdings Limited is a Hong Kong‑based fintech company offering fully digital brokerage, wealth management, and investing services via its Futubull and moomoo platforms, including trading, market data, financing, and global asset access to individual and institutional investors.
3. Palantir Technologies Inc. (NASDAQ:PLTR)
TTM Net Income: $2.28 billion
Palantir Technologies Inc. (NASDAQ:PLTR) is one of the most profitable growth stocks to buy. On June 4, Palantir Technologies and Kirkland & Ellis launched a proprietary enterprise platform built on Palantir’s Artificial Intelligence Platform/AIP to transform private equity fundraising. By integrating Kirkland’s institutional legal knowledge and market expertise into a unified operational system, the platform streamlines complex fund formation workflows, including documentation, compliance, and investor relations, for over 1,000 lawyers.
Unlike standard legal AI, this fund formation engine structures and scales Kirkland’s proprietary tradecraft across the entire fundraising lifecycle. It links transaction history, legal obligations, and market data into a single interface, enabling the firm to improve speed, transparency, and decision-making for clients managing increasingly complex global capital raises.
This multiyear partnership aims to redefine professional services by creating an enterprise operating system that continuously compounds the firm’s collective judgment. The platform supports end-to-end efficiency, helping general partners and limited partners navigate evolving regulatory and commercial frameworks more effectively.
Palantir Technologies Inc. is a software company that develops and deploys data integration and analytics platforms for government agencies, defense organizations, and enterprise clients. Its notable products include Palantir Gotham, Foundry, and Apollo.
2. Eli Lilly and Company (NYSE:LLY)
TTM Net Income: $25.28 billion
Eli Lilly and Company (NYSE: LLY) is one of the most profitable growth stocks to buy. On June 7, Eli Lilly’s oral GLP-1 medication, Foundayo (orforglipron), demonstrated significant efficacy in promoting weight loss for women across all stages of menopause. Results from post-hoc analyses of the ATTAIN-1 and ATTAIN-2 clinical trials, presented at the American Diabetes Association’s 86th Scientific Sessions, indicate that women taking the highest dose experienced substantial weight reduction regardless of whether they were pre-, peri-, or post-menopausal.
In the ATTAIN-1 trial, women achieved weight losses of up to 30.4 lbs (14.4%) in perimenopause and 28.2 lbs (14.1%) in post-menopause over 72 weeks. Similar trends were observed in the ATTAIN-2 trial, which included participants living with type 2 diabetes, where post-menopausal women saw weight loss of up to 27.8 lbs (13.6%). Additionally, participants across both studies reported meaningful reductions in waist circumference, suggesting a decrease in abdominal fat and associated cardiometabolic risks.
These findings address a critical gap in obesity care, as hormonal changes during menopause frequently accelerate fat accumulation and complicate weight management efforts. As a once-daily, non-peptide oral medication that does not require food or water restrictions, Foundayo offers a flexible treatment option for women navigating the biological challenges of this life stage.
Eli Lilly and Company is a healthcare company that develops human pharmaceutical products across cardiometabolic health, oncology, and immunology.
1. NVIDIA Corporation (NASDAQ:NVDA)
TTM Net Income: $159.61 billion
NVIDIA Corporation (NASDAQ:NVDA) is one of the most profitable growth stocks to buy. On June 7, Reuters reported that NVIDIA and SK are set to announce a new cooperation plan on Monday, following a meeting between NVIDIA CEO Jensen Huang and SK Group Chairman Chey Tae-won in Seoul. While specific details of the partnership remain under wraps, both companies confirmed that executives plan to brief the media on their joint efforts in AI supercomputing, CPUs, robotics, and other high-demand sectors.
During his visit, Jensen Huang emphasized that the current global semiconductor supply chain, ranging from wafers and packaging to silicon photonics, is facing unprecedented strain. He warned that the industry-wide memory shortage is driven by exceptionally high demand and is expected to persist for “quite a few years.”
This collaboration comes at a critical time as NVIDIA Corporation continues to navigate a constrained supply landscape. By coordinating with key partners like SK Hynix, the companies aim to address better the complex demands of the AI infrastructure market, which currently spans everything from supercomputers to next-generation personal computing hardware.
NVIDIA Corporation is a fabless semiconductor and AI computing company that designs GPUs, AI accelerators, Application Programming Interfaces/APIs, and system-on-a-chip units. Through its CUDA ecosystem, the company enables industries ranging from autonomous vehicles to scientific research by advancing AI, accelerated computing, and data center infrastructure.
READ NEXT: 10 Best Growth Stocks Under $20 to Buy and 8 Best Quality Growth Stocks to Buy.
